Loading company…
Progyny, Inc. provides fertility, family planning and women's health benefits to employers, based in New York, US.
Founded in 2015 and headquartered in New York, US, Progyny sells women's health and family building benefits to more than 530 client organizations, including fertility, pregnancy, postpartum and menopause support delivered through a network of over 1,000 providers. CEO David Schlanger leads the company. Its IPO on October 24, 2019 raised USD 130 mn, and it reported revenue of USD 1,088.60 mn and EBITDA of USD 64.46 mn in fiscal 2023. The company is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in